Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-27
1993-09-07
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540455, 540456, A61K 3142, C07D49708
Patent
active
052429385
ABSTRACT:
Dicarbonyloxy, carbonyloxy, carbanilate, and dihydroxy derivatives of Virginiamycin M.sub.1 are useful antibiotics and effectively bind gastrin and brain CCK receptors.
REFERENCES:
patent: 4762923 (1988-08-01), Lam et al.
patent: 4772595 (1988-09-01), Lam et al.
patent: 4859690 (1989-08-01), Lam et al.
patent: 4894370 (1990-01-01), Lam et al.
patent: 4942230 (1990-07-01), Lam et al.
patent: 5006466 (1991-04-01), Lam et al.
Anteunis, et al., Bull. Soc. Chim. Belg., 97(3), 209-217 (1988).
Le Goffic, J. Antimicrob. Chemo., 16 Supp. A, 13-21 (1985).
De Meester, et al., J. Antibiotics, 29(12), 1297-1305 (1976).
Lam, et al., J. Antibiotics, 44(6), 613-625 (1991).
Billups Richard C.
Bond Robert T.
Merck & Co. , Inc.
Thies J. Eric
LandOfFree
Derivatives of virginiamycin M1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of virginiamycin M1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of virginiamycin M1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-488074